Side-by-side financials for DERM and LLY. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DERM | LLY |
|---|---|---|
| Market cap | - | $1.093 T |
| US-listed rank | - | #11 |
| Revenue (latest FY) | $61.86M | $65.18B |
| Net income (latest FY) | -$11.43M | $20.64B |
| Net margin | -18.5% | 31.7% |
| P/E (trailing FY) | - | 53.0 |
| SEC filings | 210 | 989 |
In their latest fiscal years, Journey Medical Corp reported $61.86M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Journey Medical Corp and ELI LILLY & Co, or browse the full rankings.